Enterohepatic physiology of 1,25-dihydroxyvitamin D3 - PubMed (original) (raw)
- PMID: 7356679
- PMCID: PMC371364
- DOI: 10.1172/JCI109669
Enterohepatic physiology of 1,25-dihydroxyvitamin D3
R Kumar et al. J Clin Invest. 1980 Feb.
Abstract
After intravenous administration of radiolabeled 1,25-dihydroxyvitamin D3 to rats, approximately 25% of the administered radioactivity appeared in the bile within 24 h. Instillation of the biliary radioactivity into the duodena of other rats was followed by recovery of 15% of the radioactivity in newly secreted bile within 24 h. The process by which products of 1,25-dihydroxyvitamin D3 were excreted in bile was not saturable in the dose range tested (0.275-650 ng). The metabolites of 1,25-dihydroxyvitamin D3 present in bile were found to be much more polar than 1,25-dihydroxyvitamin D3 and were resolved into three fractions on high performance liquid chromatography. 60% of the radioactivity present in bile was retained selectively by DEAE-cellulose; the radioactive material could be eluted from the gel at a low pH or at high salt concentrations. When bile containing the radiolabeled metabolites was incubated at 37 degrees C and pH 5 with beta-glucuronidase, there was an increase in the amount of radioactivity comigrating with 1,25-dihydroxyvitamin D3. Treatment of the products of radiolabeled 1,25-dihydroxyvitamin D3 in bile with diazomethane, an agent which converts acids into methyl esters, transformed one of the metabolites into a less polar compound. These results demonstrate that there is a quantitatively important enterophepatic circulation of the products of 1,25-dihydroxyvitamin D3 in the rat.
References
- J Clin Invest. 1967 Jun;46(6):983-92 - PubMed
- Biochem J. 1969 Dec;115(4):663-9 - PubMed
- J Biol Chem. 1972 Dec 10;247(23):7528-32 - PubMed
- Proc Soc Exp Biol Med. 1975 Jun;149(2):570-2 - PubMed
- Biochem Biophys Res Commun. 1976 Mar 8;69(1):197-200 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources